145 related articles for article (PubMed ID: 23701999)
1. Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives.
Arpicco S; Stella B; Schiavon O; Milla P; Zonari D; Cattel L
Int J Pharm; 2013 Oct; 454(2):653-9. PubMed ID: 23701999
[TBL] [Abstract][Full Text] [Related]
2. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
Lundberg BB
Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
[TBL] [Abstract][Full Text] [Related]
4. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of paclitaxel-2'-glycinate conjugated to poly(ethylene glycol): a water-soluble prodrug.
Pendri A; Conover CD; Greenwald RB
Anticancer Drug Des; 1998 Jul; 13(5):387-95. PubMed ID: 9702205
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs.
Ryu BY; Sohn JS; Hess M; Choi SK; Choi JK; Jo BW
J Biomater Sci Polym Ed; 2008; 19(3):311-24. PubMed ID: 18325233
[TBL] [Abstract][Full Text] [Related]
7. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.
Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q
J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol)-human serum albumin-paclitaxel conjugates: preparation, characterization and pharmacokinetics.
Dosio F; Arpicco S; Brusa P; Stella B; Cattel L
J Control Release; 2001 Sep; 76(1-2):107-17. PubMed ID: 11532317
[TBL] [Abstract][Full Text] [Related]
9. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
10. Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles.
Cho YW; Lee J; Lee SC; Huh KM; Park K
J Control Release; 2004 Jun; 97(2):249-57. PubMed ID: 15196752
[TBL] [Abstract][Full Text] [Related]
11. Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol).
Wu L; Tang C; Yin C
Drug Dev Ind Pharm; 2010 Apr; 36(4):439-48. PubMed ID: 19824865
[TBL] [Abstract][Full Text] [Related]
12. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
Greenwald RB; Gilbert CW; Pendri A; Conover CD; Xia J; Martinez A
J Med Chem; 1996 Jan; 39(2):424-31. PubMed ID: 8558510
[TBL] [Abstract][Full Text] [Related]
13. Preparation of copolymer paclitaxel covalently linked via a disulfide bond and its application on controlled drug delivery.
Chen W; Shi Y; Feng H; Du M; Zhang JZ; Hu J; Yang D
J Phys Chem B; 2012 Aug; 116(30):9231-7. PubMed ID: 22774761
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.
Zhang L; He Y; Ma G; Song C; Sun H
Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
16. Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graft-carbon nanotubes for potent cancer therapeutics.
Lay CL; Liu HQ; Tan HR; Liu Y
Nanotechnology; 2010 Feb; 21(6):065101. PubMed ID: 20057024
[TBL] [Abstract][Full Text] [Related]
17. A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer.
Xie Z; Guan H; Chen X; Lu C; Chen L; Hu X; Shi Q; Jing X
J Control Release; 2007 Feb; 117(2):210-6. PubMed ID: 17188776
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of a novel polydepsipeptide contained tri-block copolymer (mPEG-PLLA-PMMD) as self-assembly micelle delivery system for paclitaxel.
Zhao Y; Li J; Yu H; Wang G; Liu W
Int J Pharm; 2012 Jul; 430(1-2):282-91. PubMed ID: 22484705
[TBL] [Abstract][Full Text] [Related]
19. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.
Khandare JJ; Jayant S; Singh A; Chandna P; Wang Y; Vorsa N; Minko T
Bioconjug Chem; 2006; 17(6):1464-72. PubMed ID: 17105225
[TBL] [Abstract][Full Text] [Related]
20. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
